US Patent Issued to Abbott Diabetes Care on Feb. 25 for "NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same" (California Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,498, issued on Feb. 25, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same" was invented by Tianmei Ouyang (Fremont, Calif.) and Benjamin J. Feldman (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Analyte sensors include an electrode having a sensing layer disposed thereon, the sensing layer comprising a polymer and an enzyme composition distributed therein. The enzyme composition includes nicotinamide adenine dinucleot...